BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹20 Cr | ₹23 Cr | ₹-1.54 Cr | ₹27 Cr | ₹22 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹20 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹-1.54 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹22 Cr |
How is Cash Flow from Operating Activities of BAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | -10.92 | |
| Mar2024 | ₹23 Cr | Positive | |
| Mar2023 | ₹-1.54 Cr | Negative | |
| Mar2022 | ₹27 Cr | 19.97 | |
| Mar2021 | ₹22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹108.4 Cr | -2.3% | -3.3% | -9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2.3% |
-3.3% |
-9.9% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses